CD8A and COVID-19: Wiech et al. reported a time-dependent (3-month vs. 6-month follow-up, after COVID-19 onset) decrease in naïve CD8+ T cell percentage in all their groups of convalescent patients according to the severity of acute disease (mild, moderate, severe), although this relative depletion was more evident in patients recovering from severe forms [34].